Clinical Trial Detail

NCT ID NCT04329065
Title Concurrent WOKVAC Vaccination, Chemotherapy, and HER2-Targeted Monoclonal Antibody Therapy Before Surgery for the Treatment of Patients With Breast Cancer
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors University of Washington
Indications

estrogen-receptor negative breast cancer

Therapies

Paclitaxel + Pertuzumab + pUMVC3-IGFBP2-HER2-IGF1R vaccine + Trastuzumab

Age Groups: adult senior

Additional content available in CKB BOOST